Cardiovascular risk assessment: a global perspective
- PMID: 25754885
- DOI: 10.1038/nrcardio.2015.28
Cardiovascular risk assessment: a global perspective
Abstract
An important strategy in primary prevention of cardiovascular diseases (CVD) is the early identification of high-risk individuals. Effective implementation of a strategy to identify these individuals in a clinical setting is reliant on the availability of appropriate CVD risk-assessment models and guideline recommendations. Several well-known models for CVD risk assessment have been developed and utilized in the USA and Europe, but might not be suitable for use in other regions or countries. Very few reports have discussed the development of risk-assessment models and recommendations from a global perspective. In this Review, we discuss why risk-assessment methods developed from studies in one geographical region or ethnic population might not be suitable for other regions or populations, and examine the availability and characteristics of predictive models in areas beyond the USA or Europe. In addition, we compare the differences in risk-assessment recommendations outlined in CVD clinical guidelines from developed and developing countries, and consider their potential effect on clinical practice. This overview of cardiovascular risk assessment from a global perspective can potentially guide low-to-middle-income countries in the development or validation of their own CVD risk-assessment models, and the formulation of recommendations in their own clinical guidelines according to local requirements.
Similar articles
-
The U.S. prevention of cardiovascular disease guidelines and implications for implementation in LMIC.Glob Heart. 2014 Dec;9(4):445-55. doi: 10.1016/j.gheart.2014.10.003. Glob Heart. 2014. PMID: 25592799 Review.
-
Global cardiovascular risk management in primary prevention.Curr Vasc Pharmacol. 2012 Nov;10(6):709-11. doi: 10.2174/157016112803520729. Curr Vasc Pharmacol. 2012. PMID: 23259561
-
[Guideline on the assessment and management of cardiovascular risk in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Jan 6;53(1):13-35. doi: 10.3760/cma.j.issn.0253-9624.2019.01.004. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 30605960 Chinese.
-
Overview of Risk-Estimation Tools for Primary Prevention of Cardiovascular Diseases in European Populations.Cent Eur J Public Health. 2015 Jun;23(2):91-9. doi: 10.21101/cejph.a4004. Cent Eur J Public Health. 2015. PMID: 26851417 Review.
-
Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?Vasc Health Risk Manag. 2015 Aug 25;11:503-6. doi: 10.2147/VHRM.S87398. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 26345154 Free PMC article.
Cited by
-
Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study.J Cardiovasc Thorac Res. 2024;16(2):88-96. doi: 10.34172/jcvtr.32906. Epub 2024 Jun 25. J Cardiovasc Thorac Res. 2024. PMID: 39253346 Free PMC article.
-
Arterial stiffness in subclinical atherosclerosis quantified with ultrafast pulse wave velocity measurements: a comparison with a healthy population using propensity score matching.Ultrasonography. 2024 Jul;43(4):263-271. doi: 10.14366/usg.24045. Epub 2024 Apr 24. Ultrasonography. 2024. PMID: 38960742 Free PMC article.
-
Prevalence and influencing factors of subjects at high risk for cardiovascular disease in different regions of Gansu province, China: a cross-sectional study of 100,725 residents from 2017 to 2022.Front Cardiovasc Med. 2024 Aug 5;11:1373123. doi: 10.3389/fcvm.2024.1373123. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39161661 Free PMC article.
-
Development of a Cardiovascular Disease Risk Prediction Model: A Preliminary Retrospective Cohort Study of a Patient Sample in Saudi Arabia.J Clin Med. 2023 Aug 4;12(15):5115. doi: 10.3390/jcm12155115. J Clin Med. 2023. PMID: 37568517 Free PMC article.
-
Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013-2018.Diabetes Metab Syndr Obes. 2021 Oct 14;14:4253-4262. doi: 10.2147/DMSO.S335017. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34703258 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical